Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Benzinga Insights

12 Health Care Stocks Moving In Friday's After-Market Session

Gainers

  • HOOKIPA Pharma (NASDAQ:HOOK) stock moved upwards by 8.5% to $2.69 during Friday's after-market session. HOOKIPA Pharma's trading volume hit 1.4 million shares by close, accounting for 40.5% of its average volume over the last 100 days. The market value of their outstanding shares is at $80.5 million.
  • Alaunos Therapeutics (NASDAQ:TCRT) stock moved upwards by 7.74% to $0.9. The market value of their outstanding shares is at $194.5 million.
  • Exscientia (NASDAQ:EXAI) shares increased by 6.32% to $19.0. The company's market cap stands at $2.2 billion.
  • Mustang Bio (NASDAQ:MBIO) shares increased by 6.29% to $0.94. The company's market cap stands at $87.8 million.
  • Clovis Oncology (NASDAQ:CLVS) stock rose 5.26% to $1.8. The market value of their outstanding shares is at $233.9 million.
  • Evoke Pharma (NASDAQ:EVOK) shares increased by 4.61% to $0.68. The company's market cap stands at $22.2 million.

Losers

  • Caladrius Biosciences (NASDAQ:CLBS) stock decreased by 8.9% to $0.7 during Friday's after-market session. The market value of their outstanding shares is at $41.8 million.
  • Modular Medical (NASDAQ:MODD) stock declined by 8.31% to $2.76. The company's market cap stands at $17.6 million.
  • Regencell Bioscience (NASDAQ:RGC) stock declined by 7.9% to $35.0. The company's market cap stands at $453.8 million.
  • Aptorum Group (NASDAQ:APM) shares declined by 3.98% to $1.69. The company's market cap stands at $60.2 million.
  • Rubius Therapeutics (NASDAQ:RUBY) shares decreased by 3.5% to $4.97. The company's market cap stands at $446.6 million.
  • Gelesis Holdings (NYSE:GLS) shares decreased by 3.16% to $3.07. The company's market cap stands at $221.6 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.